Altered caveolin-3 expression disrupts PI(3) kinase signaling leading to death of cultured muscle cells. (Q40260692)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814768%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Altered caveolin-3 expression disrupts PI(3) kinase signaling leading to death of cultured muscle cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814768%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814768%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Thomas A. Rando

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814768%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

2

Thomas A Rando

1 reference

19 September 2017

Gayle M Smythe

1

1 reference

19 September 2017

language of work or name

English

0 references

publication date

23 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814768%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814768%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814768%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814768%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

2816-2825

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814768%20AND%20SRC:MED&resulttype=core&format=json

Membrane microdomains and caveolae

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Emerging themes in lipid rafts and caveolae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

A detergent-free method for purifying caveolae membrane from tissue culture cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

IGF-I induces caveolin 1 tyrosine phosphorylation and translocation in the lipid rafts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Unexpectedly strong binding of a large metal ion (Bi3+) to human serum transferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolae: from cell biology to animal physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolin, caveolae, and endothelial cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

M-caveolin, a muscle-specific caveolin-related protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolin-3 in muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Increased caveolin-3 levels in mdx mouse muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Inhibition of lipid raft-dependent signaling by a dystrophy-associated mutant of caveolin-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

PI 3-kinase, Akt and cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

The phosphoinositide 3-kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Effect of insulin on caveolin-enriched membrane domains in rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolae participate in tumor necrosis factor receptor 1 signaling and internalization in a human endothelial cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Modulation of the caveolin-3 and Akt status in caveolae by insulin resistance in H9c2 cardiomyoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolin-induced activation of the phosphatidylinositol 3-kinase/Akt pathway increases arsenite cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Caveolins and caveolae: molecular and functional relationships.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

Mutations in the caveolin-3 gene: When are they pathogenic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2006.05.010

10.1016/J.YEXCR.2006.05.010

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16814768%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference